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ABSTRACT
Purpose: Study hemodynamic pattern and lipoperoxidation during methylene blue (MB) treatment on taurocholate -
enterokinase induced acute pancreatitis (AP). Methods: Thirty pigs were equally divided in control group; MB group; AP
group; MB previous AP group; and MB after 90 min of induced AP group. MB was given iv in a bolus dose (2mg.kg-1)
followed by maintenance dose (2 mg.kg-1.h-1). Hemodynamic parameters were recorded continuously during 180 min by
Swan-Ganz catheter. Blood samples were taken every 60 min to determine arterial and venous nitrate, malondialdehyde
(MDA) and amylase. Pancreatic tissue was removed for histopathologic study. Results: In AP group MBP and CO
decreased over time 33% (p<0.05) and 52% (p<0.05), respectively. In MB previous induced-AP group, there was 70
minutes delay (p<0.05) to decrease MBP and CO. In MB group arterial and venous nitrite decreased (p<0.05) over time. MB
infusion increased (p>0.05) serum MDA when associated to AP. After induced AP, MB did not reverse MBP and CO
decrease. There was no difference in serum amylase and necro-hemorrhagic findings with MB treatment. Conclusions: In
this taurocholate-induced AP model MB treatment delayed hemodynamic shock and decreases serum nitrate levels but
increases serum MDA levels. No volemic replacement was done and it may have been a mitigated factor to a poor tissue
perfusion and impairment microcirculation. Further investigations are needed to elucidate MB treatment role during AP
treatment.
Key words: Acute Pancreatitis. Methylene Blue. Nitric Oxide. Shock. Lipoperoxidation. Taurocholate.
RESUMO
Objetivo: estudar o perfil hemodinâmico e a lipoperoxidação durante o tratamento com azul de metileno (AM) de pancreatite
aguda (PA) induzida por taurocolato-enteroquinase. Métodos: Trinta porcos foram igualmente divididos em: grupo controle,
grupo AM; grupo PA; grupo AM prévio à PA; grupo AM após 90 minutos após a indução da PA. O AM foi administrado
sob a forma de bolus EV (2mg.kg-1)  seguido por dose de manutenção (2 mg.kg-1.h-1). Os parâmetros hemodinâmicos
foram registrados continuamente durante 180 min com auxílio de cateter de Swan-Ganz.  Amostras sanguíneas foram
colhidas a cada 60 min para a determinação arterial e venosa de nitrato, malondialdeido (MDA) and amilase. Removeu-se
tecido pancreático para estudo histopatológico. Resultados:  No grupo PA a pressão arterial media (PAM) e o débito
cardíaco (DC) diminuíram respectivamente 33% (p<0.05) e 52% (p<0.05) no decorrer do tempo. No grupo AM prévio à
indução da PA ocorreu 70 minutes de demora (p<0.05) para as diminuições da PAM e DC. No grupo AM houve diminuição
temporal do nitrato arterial e venoso (p<0.05). A infusão de AM aumentou os valores de MDA sérico quando associado a
PA (p>0.05). Após a indução da PA a infusão de AM não reverteu as quedas da PA e DC. Não houve diferenças nos níveis
de amilase sérica e achados histológicos com o tratamento com o azul de metileno. Conclusões: No presente modelo de PA
induzida por taurocolato o AM retardou o desenvolvimento do choque circulatório, diminuiu os níveis de nitrato mas
aumentou os níveis de MDA. Não se realizou nenhum tipo de reposição volêmica que poderia melhorar a perfusão tecidual
e melhora da microcirculação. Investigações adicionais são necessárias para elucidar o papel terapêutico do AM no
tratamento da PA aguda.
Descritores: Pancreatite Aguda. Azul de Metileno. Óxido Nítrico. Choque Circulatório. Lipoperoxidação. Taurocolato.
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Introduction
The nitric oxide (NO) role in acute pancreatitis
(AP) pathogenesis remains controversial1 with some
studies suggesting that it potentiates the oxidative stress
and pancreatic parenchyma injury,2,3 while others report
that it reduces the pancreatic dysfunction by increasing
pancreatic blood flow in response to NO releasing by
endothelial cells.4-7
NO is synthesized from L-arginine by action of a
single enzyme, oxide nitric synthase (NOS). NO action can
be blocked by methylene blue (MB), a GMPc inhibitor.8,9
MB blocks GMP-c increase, the ultimate effector pathway
of NO production with vasodilatation action. MB also may
inhibit the NO synthesis.
MB clinical use has been reported in sepses, renal
and hepatic transplantation, anaphylactic shock and shock
associated to extracorporal circulation.
In the present study, MB was employed to
evaluated the hemodynamic and biochemical effects in a
severe AP model in pigs.10,11
Methods
Surgical preparation of the animals. Thirty
healthy male Dalland pigs weighing between 20 to 24 kg
were studied at the Laboratory of Experimental Surgery,
Department of Surgery and Anatomy, Faculdade de
Medicina de Ribeirão Preto, University of São Paulo (FMRP-
USP). The experimental model protocol and animal handling
as well procedures were approved by the Committee of
Ethics in Research of the FMRP-USP. Before the procedure
all animals had a 12 hour fasting period except by water
adlibitum.
The animals were anaesthetized with Midazolan
(15 mg i.m. Cristália Chemical Products Ltda., Itapira, S.P.,
Brazil) and Tiletamine/Zolazepam (10 mg.kg-1 body weight
- Telazol®, Fort Dodge, WI, USA) followed by a continuous
i.v. infusion of Sulfentanil in the dose of 100 mg.h-1
(Fastfan®, Cristália Chemical Products Ltda., Itapira, S.P.,
Brazil) and Propofol (10 mg.kg-1.h-1 Propovan®, Cristália
Chemical Products Ltda., Itapira, S.P., Brazil) using a syringe
pump (Syringe Infusion Pump, Harvard Apparatus, South
Natick, Me, U.S.A.). Muscle relaxation was obtained with
acid pancuronic (6 mg.h-1 Pancuron®, Cristália Chemical
Products Ltda., Itapira, S.P., Brazil). The animals received 3
ml of sodium chloride 0,9%.kg-1 body weight.h-1 i.v. to
compensate insensitive losses. During the procedure the
animals were kept in mechanic ventilation (Takaoka-
Model6000) with FiO2 of 40% and a intratracheal pressure
of 8 mmHg. Venous access was obtained throughout the
right jugular vein and a Swan-Ganz catheter (CCOmbo CCO/
SvO2 744HF75 Edwards Lifesciences, Irvine, CA, U.S.A)
was introduced. Arterial access was obtained throughout
the right femoral artery and a polyethylene catheter was
introduced. The abdominal wall was opened by a midline
incision extending about 15cm from the xiphoid region. The
duodenum as well the main pancreatic duct were identified.
The main pancreatic duct was carefully isolated, opened
and canalled using a catheter as described previously.11
The pancreatic catheter was exteriorized throughout the
abdominal incision that  was closed in a continuously
fashion.
Data Collection. After surgical and anaesthetic
procedures had been accomplishment including
tracheostomy, venous and arterial access, hemodynamic
monitoring, blood samples collection, main pancreatic duct
cannulation, the animals were observed by a period of 45
minutes for hemodynamic stability. After this stability
period, hemodynamic parameters were collected and
registered continuously for 180 min using a MP System 100
(BioPacSystem, Incorporation, Santa Barbara, CA, U.S.A.).
Arterial and venous blood samples were collected to
biochemical analyses every 60 min from the beginning of
the experiment (instant zero).
Experimental Protocol. Group Control (CTL)
(n=6): the animals received in sequence: a) 20 mL i.v. “bolus”
of saline followed by saline maintenance (3 mL.kg-1 body
weight.h-1 i.v.) b) continuous infusion of saline during the
period of 1 min in the main pancreatic duct; Group MB (n=6):
the animals received in sequence: a) MB solution i.v.; b)
continuous infusion of saline during the period of 1 min in
the main pancreatic duct; Group AP (n=6): the animals
received in sequence: a) 20 mL i.v. “bolus” of saline followed
by saline maintenance (3 mL.kg-1 body weight.h-1 i.v.) b)
AP induction; Group MB plus AP (n=6): the animals received
in sequence:  MB solution i.v.; b) AP induction; Group AP
plus MB (n=6): the animals received in sequence: a) 20 mL
i.v. “bolus” of saline followed by saline maintenance (3
mL.kg-1 body weight.h-1 i.v.) b) AP induction; c) after 90
minutes of AP induction, MB solution i.v..
AP induction. AP was induced immediately after
basal parameters of hemodynamic, arterial and venous blood
samples were collected. In brief, a continuous intraductal
infusion of a 5% solution of sodium taurocholate (Sigma,
St. Louis, Me, USA) in a dose of 1ml.kg-1 body weight with
enterokinase (Sigma, St. Louis, Me, USA) in a dose of 8U.kg-
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1 body weight during a 1 minute period was performed as
described also were.10,11
MB infusion. MB (Merck Diagnostica, Darmstadt,
Germany) infusion was carried through an initial dose of
2mg.kg-1 body weight diluted in 20 ml of 0,9% sodium
chloride solution followed by a maintenance dose of 2
mg.kg-1 body weight.h-1 was done by a continuous
intravenous infusion throughout the experiment.
Nitrate Dosage. Serum nitrate was indirectly
measured by a Sievers NOAnalizer 280i using a NO/ozone
chemioluminiscence technique.12
Malondialdehyde Dosage. MDA dosage was
done using a Lipid Peroxidation Assay (Calbiochem San
Diego, CA, U.S.A) as described previously.13
Biochemical Serum Analysis. Amilase, glicemia,
creatinin , hematocrit, blood gas analyze were done using
either a Stat Profile 9 Plus Analyzer (New Biomedical Co.,
ME, USA.) or a RapidLab 860 (Chiron Diagnostics Co.,Me,
the U.S.A) or COULTER T-540 (Coulter Co., FL, U.S.A) or a
Dimension device AIR (Dade Behring Incorporation,
Deerfield, IL, U.S.A).
Pancreas Biopsy and Morphologic Study. At the
end of data collection the previous laparotomy was extended
from the xiphoid to the suprapubic region and the animals
were sacrificed by exsanguination. The pancreas was
identified, isolated and removed in all its extension. The
pancreas was immediately fixed in a 10% formol solution,
after which time the slides were prepared from paraffin
blocks and stained with hematoxylin-eosin stain. Biopsy
samples from all 30 animals were then examined blindly in
order to eliminate observer bias. The slides were screened
under light microscope for swelling, inflammatory
infiltration, necrosis and hemorrhage.
Statistical Analysis
The results were expressed in arithmetic mean and
standard deviation (sd). Serum amylase, glucose, creatinin
and hematocrit were analyzed in 60 minutes intervals from
time zero. Collected data were stored in a computer and plot
in spread sheets of the Excel program (Microsoft, Seatle,
WA, the U.S.A), and statistically analyzed using a Minitab
12.2.2 software (Minitab Incorporation, State College, PA,
USA) and a S-Plus 3.3 software (Mathsoft Engineering &
Education Incorporation, Cambrigde, MA, U.S.A). The
longitudinal comparisons were made by analysis of variance
for repeated measures, and each instant for analysis of
variance (ANOVA) with comparisons of Tukey, or Kruskal-
Wallis test, based on rank sum. Fisher‘s angular
transformation was used to express results in percentage. P
<0.05 were considered statistically significant.
Results
Hemodynamic results are summarized in Table 1.
Figure 1 illustrate the continuously alterations in CO that
occurred in all groups. MBP, CVP, PCP, CO, CI and DO2
decreased (p<0.05) over time in all AP groups. HR increased
(p<.005) in all AP groups over time. SVR and PVR increased
(p<0.05) in AP and AP+MB groups. In MB+AP group, there
was a 70 minutes delay in the MBP and CO decrease (p<0.05)
when compared to AP group. DO2 diminished in all AP
groups although MB immediately before AP induction
delayed DO2 decrease. O2EI increased (p<0.05) in all AP
groups.
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FIGURE 1  -     Cardiac output (CO) results in all groups. In
AP group CO decreased 52% (p<0.05) over
time. In MB+AP group, there was 70
minutes delay (p<0.05) to decrease CO
compared to AP group. MB after AP
induction did not improve (p<0.05) CO.
CTL (control group), MB (methylene blue
group), AP (acute pancreatitis group), MB
(methylene blue group), MB+AP
(methylene blue plus acute pancreatitis
group), AP+ MB (acute pancreatitis plus
methylene blue group).
* p<0.05 versus t (0)
† p<0.05  CTL versus AP
                           ‡ p<0.05 MB versus MB+AP
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Table 2 shows the results of serum nitrate arterial
and venous and amilase. Serum arterial nitrate decreased
continuously (p<0.05) in MB group over time. Serum arterial
nitrate increased (p<0.05) in both AP and MB+AP groups
when compared to CTL and MB groups at 180 min,
respectively.
Serum venous nitrate decreased (p<0.05) in MB
group at 180 min. In contrast, serum venous nitrate increased
(p<0.05) in AP group at 180 min. Serum venous nitrate
increased (p<0.05) in both AP and MB+AP groups when
compared to CTL and MB groups at 180 min, respectively.
MDA increased (p<0.05) in MB group at 180 min. In the
MB+AP group MDA increased (p<0.05) at 60, 120 and 180
min.  In the AP+MB group MDA increased (p<0.05) at 120
and 180 min. MDA in MB group was elevated (p<0.05) when
compared to CTL group at 180 min. MDA in MB+AP group
were elevated (p<0.05) when compared to MB and AP
groups at 60, 120 and 180 min. It were also elevated (p<0.05)
in AP+MB group when compared to AP group at 120 and
180 min. (Figure 2).
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FIGURE 2   -         Malondialdehyde (MDA) relative variation
in all groups. CTL (control group), MB
(methylene blue group), AP (acute
pancreatitis group), MB (methylene blue
group), MB+AP (methylene blue plus acute
pancreatitis group), AP+ MB (acute
pancreatitis plus methylene blue group). *
p<0.05 versus t (0); † p<0.05  CTL versus
AP; ‡ p<0.05 AP versus AP+MB; # p<0.05
MB versus MB+AP
TABLE 2 - Serum arterial and venous nitrate and serum amylase results in all groups.
         Arterial Nitrate (mM)                                 Venous Nitrate (mM)                                   Amylase (UI.L-1)
Time(min)    0                        60                       120                      180                0                   60                     120               180                      0                     60                     120                    180
CTL            93(56)             94(40)              91(41)                80(38)           97(59)         90(38)          83(34)          75(40)       1507(656)    1409(616)          1388(625)      1371(612)
MB             116(41)          108(40)*             102(37)*        96(32)*‡  112(38)       110(39)       104(39)       94(33)*‡     1690(436)    1576(419)        1575(432)      1552(434)
AP                 99(22)            99(31)            104(31)      116(33)†        97(21)          97(31)        102(32) 114(39)*†     1714(257)   2183(191)*†   1679(1365)   2166(1146)
MB+AP   169(105)         161(97)              172(115)         188(112) 168(110)     155(94)   174(112)    184(116)       1210(466)   2004(336)*     1758(1354)  2728(822)*
AP+ MB      94(11) 92(10)          98(17)          105(20)            93(7)          93(14)        96(18)     101(15)    1423(165)   2231(1467)*   2483(2304)  3757(199)*
CTL (control group), MB (methylene blue group), AP (acute pancreatitis group), MB+AP (methylene blue plus acute pancreatitis group),
AP+ MB (acute pancreatitis plus methylene blue group). Values are present as mean (standard deviation). Values are present as mean
(standard deviation).
* p<0.05 versus t (0); † p<0.05 versus CTL; ‡ p<0.05 MB versus MB+AP
TABLE 3 - Serum glucose, creatinine and hematocrit results in all groups.
               Glucose (mg.dL-1)                                                                    Cr (mg.dL-1)                                                                         Ht (%)
Time(min) 0                   60                    120             180                   0                   60            120             180                     0                 60                  120 180
CTL 108(15)          100(18)             93(13)     93(8)  0.9(0.1)      0.9(0.1)     0.9(0.1)  0.9(0.1)             30(2)          28(2)      28(3)   29(3)
MB                      108(30)            76(22)               70(26)*      63(28)*   1.1 (0.2)     1.1(0.2)     1.1(0.2)     1.1(0.2)              32(2)          30(2)             31(2)       31(2)
A P 120(19)*         72(14)               64(22)     58(12)*  0.8 (0.1)     0.8(0.1)     1.0 (0.1) 1.1(0.1)*            35(3)          37(3)†      42(2)* †      46(2)* †
MB+AP 124(29)*           59(17)             55(11)*     51(18)*   0.9(0.1)      1.0(0.2)     1.1 (0.2)    1.2(0.2)*    32(1)           34(1)           38(2)*  41(3)*
AP+ MB 138(49)*          60(12)              64(26)     61(26)*  0.9(0.1)      0.8(0.1)     1.1(0.1) ‡ 1.3(0.1)*           34(3)           35(2) #      39(2)* #      40(1)* #
CTL (control group), MB (methylene blue group), AP (acute pancreatitis group), MB+AP (methylene blue plus acute pancreatitis group), AP+
MB (acute pancreatitis plus methylene blue group). Values are present as mean (standard deviation).
* p<0.05 versus t (0); † p<0.05 versus CTL; ‡ p<0.05 AP versus AP+MB; # p<0.05 MB versus MB+AP
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Serum amylase levels were elevated (p<0.05) in AP
group at 60 min. Serum amylase levels were elevated (p<0.05)
in MB+AP and AP+MB groups at 60 and 180 min. There
was increased (p<0.05) serum amylase when compared CTL
group to AP group at 60 min.
Serum glucose, creatinin and hematocrit results are
showed in Table 3. Serum glucose levels decreased (p<0.05)
in MB group at 120 and 180 min; in MB+AP group at 60, 120
and 180 min; in AP and AP+MB groups at 60 and 180 min.
No difference (p>0.05) were seen among groups.
Creatinin serum levels increased (p<0.05) in all AP
groups AP at 180 min, moreover in AP+MB group that
increased (p<0.05) at 120 min. Creatinin serum levels were
elevated (p<0.05) in MB+AP group when compared to AP
group at 180 min.
Hematocrit increased (p<0.05) in all AP groups. At
the end of the experiment, there were a mean increase of 32,
26, and 20 % in AP, MB+AP and AP+MB groups,
respectively.
Pancreatic morphological study from CTL and MB
groups showed normal gland. However, pancreas from all
AP groups presented with bright dark reddish surface with
black spots, swelled and jelly consistence. Microscopy
study in CTL and MB groups was unremarkable but it
revealed necrosis and hemorrhage in all AP groups. None
leukocytes infiltration was seen.
Discussion
MB has been used as a therapeutic drug for more
than 110 years14 mainly for methemoglobinemia treatment,
cyanate antidote and fistula localization.15 In AP group,
venous nitrate levels increased over time and arterial nitrate
levels were higher when compared with group CTL. This
increase was associated with hypotension, CO and PCP
decrease and hemoconcentration. In severe AP, inducible
nitric oxide synthase (iNOS) overproduces NO. Excessive
NO production cause pathological vasodilatation with
capillary permeability increase and third space fluid loss16
and tissue injury by NO derived free-radicals
overproduction. AL MUFTI et al. (1998) demonstrated an
increase in iNOS activity associated to systemic NO
increase and arterial hypotension in AP experimental
models.17,18 Thus, inhibition of iNOS may have a potential
benefic effect in a variety of pathophysiologic alterations
in AP.
The findings of MBP, CVP, CO and CI reduction in
AP group associated to HR, SVR and PVR increase with
hemoconcentration confirm the method reproducibility
regarding precocious hypovolemic shock manifestations
in this AP experimental model.19 CO and CI reduction during
AP induction is primarily related to hypovolemia and due
to preload reduction.20 Experimental studies had
demonstrated that MBP decrease correspond to 26 to 45%
circulating volume decrease21,22 In this study it was 32% in
AP group.
Our objective was to evaluate initial AP treatment
with MB without volemic replacement. When compared AP
groups there was a delay in CO and CI reduction in MB+AP
group although there were no difference at the end of the
experiment. In AP group it initiated at 70 minutes and only
at 140 minutes in MB+AP group. However, MB given 90
minutes after AP induction, did not revert the hemodynamic
changes. When there is volemic replacement, CO and CI do
not decrease in severe AP initial phase and
hemoconcentration precedes hemodynamic alteration23
Hemoconcentration was present 10 minutes before CO and
CI decrease in AP group. Furthermore, in MB+AP group
occurred hemoconcentration at least 50 minutes before CO
and CI decrease. We observed that MB (dose of 2mg.kg-1.h-
1) increased PVR, that also was reported in shock septic
patients treated with MB (4mg.kg-1.h-1)24 MB inhibition on
NO vasodilatation and prostaglandins action may explain
PVR increase in septic shock and inflammatory conditions
where both action are increased25 differently from normal
physiological conditions as seen in MB group.
DO2 diminished in AP groups although MB
immediately before AP induction delayed DO2 decrease,
most probably related to CO decrease. O2EI increase
observed in AP groups reflects AP hypovolemic condition
and it suggests a compensation attempt due to DO2 decrease
and VO2 increase.26 However, AP patients that had volemic
correction with crystalloid solutions present DO2 and VO2
increase suggesting that AP increases metabolic demand.26
Serum nitrate levels increase was not observed
when MB was used either before or after AP induction. An
unexpected reduction of arterial and venous serum nitrate
levels were observed suggesting inhibition of NO effect
independent of GMPc inhibition27. However, this effect
seems partial because MB did not decrease serum  nitrate
levels in the MB+AP or AP+MB groups. This mechanism
can be due to the production of superoxide, a NO inactivator.
Oxidatio of the reduced form of MB induces the generation
of this free radical27,28, justifying the findings of MDA
increases associated to MB infusion”.
Free radicals (FR) generation seems to be involved
in AP experimental models correlated to ischemia, alcohol
and biliary etiology.29,30 However, MDA serum levels did
not increased in AP group. Different experimental models
of AP seem to present different degrees and mechanisms of
FR formation, with lesser impact in taurocholate-induced
AP.30 Adversely, MB promoted increase of MDA serum
levels with a significant impact when it was associated with
AP. There are evidence that L-NAME induces the RL
production31,32. MARCZIN et al.33 had demonstrated that,
in physiological conditions, MB inactives NO with
consequent increase in superoxide concentration and
lipoperoxidation.34 Therefore, it seems that MDA serum
increase in group MB corresponds probably to NO
inactivation with consequent NO physiological actions
blockage. MDA levels increase, associated with the use of
MB during AP, seems not to be associated to initial NO
production by iNOS. The NO release, in great amounts,
demand necessary time since the initial stimulation to its
final production that involves cellular enzymatic
mechanisms. The NO increase occurred 180 min after AP
induction.
NO may be a cytotoxic mediator during
taurocholate-induced AP.3 In fact, NO cytotoxicity is
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attributed to its reaction with ion superoxide forming
peroxynitrite.35,36 Although peroxynitrite production
precedes iNOS expression, there was no MDA increase in
AP group.
Initial studies in sepsis had shown that NO
overproduction is responsible by hypotension and that
iNOS blockage improves it without improving mortality.37-39
The reason is due to no selective iNOS inhibitors, that NO
blocking interferes with perfusion regulation, capillary
permeability and leukocytes/platelets interactions. A
possible explanation for these findings may be that NO
blockage by MB improved systemic hemodynamic
parameters during AP, although in the cellular level it
promoted a poor tissue perfusion due to its vasoconstrictor
action. Moreover, MB increases platelets activity in
hypovolemic and hemoconcentration conditions
propitiating lipoperoxidation and tissue perfusion
aggravation. Serum amylase levels increase, MB+AP and
AP+MB groups, may correspond to suppression of NO
beneficial effect in pancreatic microcirculation. NO is a
mediator that increases pancreatic blood flow in response
to physiological stimulation of CCK and secretin.40 NO may
confer protection against AP development, probably due
to pancreatic microcirculation improvement and leukocytes
adhesion reduction.41-43
Serum creatinin increase in AP groups is in
accordance with LEVY et al.44 that demonstrated acute renal
insufficiency consequence to hypovolemia in taurocholate-
induced AP model. Serum creatinin worsening in AP+MB
group confirms MB vasoconstrictor effect on renal
circulation thus aggravating a vasoconstriction due to
hypovolemia.
Hypoglycemia occurred in all groups except in
group CTL. Hypoglycemia in AP groups may be explained
by cells beta destruction and insulin release during
taurocholate-induction AP. On the other hand, MB group
also presented hypoglycemia over time probably due to a
blockage of an insulin inhibitory secretion mechanism NO
dependent.45,46 There was no improvement in necro-
hemorrhagic findings with MB treatment.
In this taurocholate-induced AP model we
concluded that MB treatment delayed hemodynamic shock
and decreases serum nitrate levels but increases serum
MDA levels. In our experiment, no volemic replacement was
done and it may have been a mitigated factor to a poor
tissue perfusion and impairment microcirculation. Further
investigations are needed to elucidate MB treatment role
during AP treatment.
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Comments:
Current literature data indicates that methylene blue may reverse or  ameliorate hemodynamic alterations caused by the
systemic inflammatory syndrome through blockage of nitric oxide activity.  Nitric oxide is a vasodilator and regulates the
exocrine and endocrine (insulin) pancreatic secretion and the microvascular blood flow.  The use of NO in acute experimental
pancreatitis shows controversial results.  Some studies (Werner et al., 1997; Molero et al., 1995) suggest a protective effect
probably due to increased blood flow in the pancreatic micro circulation.  Waindebach et al. (1995) did not observe any
effect of NO in acute pancreatitis, but others (Dabrowiski et al.,1994; Iomis et al., 1995)  had evidence of an injurious effect,
thought to be  due to oxidative stress, vasodilatation  and tissue hypoperfusion. In this study, Meirelles et al. proposed the
study of hemodynamic profiles and lipid peroxidation in pigs with acute pancreatitis induced by taurocholate enterokinase,
and submitted to treatment with methylene blue, as a NO inhibitor, before and after pancreatitis induction.  The dye was
able to reduce  serum nitrate levels, but lipid peroxidation was increased as shown by serum levels of malon dialdehyde.
The results in the study warrant the conclusion that the use of  methylene blue before induction of severe acute experimental
pancreatitis offered a transitory protection to hemodynamic shock. However, there was a deleterious effect on  lipid
peroxidation and  the claim that there is an improvement in circulatory shock by the use of methylene blue should be
avoided.
Rafael Kemp
MD, Assistant, Division of Digestive Surgery, Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine,
University of São Paulo,  Brazil
José Sebastião dos Santos
PhD, Professor, Division of Digestive Surgery,  Department of Surgery and Anatomy, Ribeirão Preto Faculty of Medicine,
University of São Paulo, Brazil.
Conflict of interest: none
Financial Source: FAPESP and FAEPA
How to cite this article:
Meirelles Jr RF, Ceneviva R, Viaro F, Evora PRB.  Methylene blue improves hemodynamic shock but increases
lipoperoxidation in severe acute pancreatitis pig model. Acta Cir Bras [serial on the Internet] 2008; 23 Suppl 1. Available
from URL: http://www.scielo.br/acb.
